A rendering of the Lithoplasty balloon catheter, screenshot--Courtesy of Shockwave Medical Medical device makers are scrambling to develop and sell advanced angioplasty balloons to treat peripheral ...

SANTA CLARA, Calif., May 19, 2022 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development of Intravascular Lithotripsy (IVL) to treat severely calcified cardiovascular ...

SANTA CLARA, Calif., Nov. 07, 2020 (GLOBE NEWSWIRE) -- Shockwave Medical, Inc. (NASDAQ: SWAV), a pioneer in the development and commercialization of Intravascular Lithotripsy (IVL) to treat severely ...

A rendering of the Lithoplasty balloon catheter, screenshot--Courtesy of Shockwave Medical Startup Shockwave Medical expects that its Lithoplasty balloon catheters will emerge as a pretreatment for ...

The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...

FREMONT, Calif.--(BUSINESS WIRE)--Shockwave Medical, a pioneer in the treatment of calcified cardiovascular disease, today announced the company’s key activities at the annual Transcatheter ...

Shockwave owns US Patent No. 8,956,371 (the “’371 patent”), which is directed to the treatment of atherosclerosis through intravascular lithotripsy. The claimed device is for a “typical over-the-wire ...

Shockwave Medical, Inc. (“Shockwave”) owns U.S. Patent No. 8,956,371 (“the ’371 patent”). This patent is directed to the treatment of atherosclerosis through intravascular lithotripsy (“IVL”). The ...